Table 1 Patients demographics
Mean age [range] | ||
|---|---|---|
56 [30–79] | ||
n | % | |
Premenopausal | 12 | 21.4 |
Postmenopausal | 44 | 78.6 |
FIGO I and II | 17 | 30.4 |
FIGO III and IV | 39 | 60.6 |
Grade 1 | 10 | 17.9 |
Grade 2 | 16 | 28.6 |
Grade 3 | 30 | 53.5 |
Serous type | 45 | 80.4 |
Mucinous type | 3 | 5.4 |
Endometriod type | 3 | 5.4 |
Clear cell type | 5 | 8.8 |
Primary optimal cytoreduction surgery | 25 | 44.6 |
Neoadjuvant chemotherapy | 31 | 55.4 |
Platinum sensitive | 30 | 53.6 |
Platinum resistant | 17 | 30.3 |
Platinum refractory | 9 | 16.1 |